Clinical Trial

Use of Mesenchymal Stem Cells in Pre-term Patients With Bronchopulmonary Dysplasia.

Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated March 17, 2025 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.
Summary
Bronchopulmonary dysplasia (BPD) is a disease that affects preterm newborn patients, preventing their lungs from developing properly. Allogeneic fetal stem mesenchymal cells from umbilical cord could reduce the prevalence of BPD in this patients.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-02-19; most recent amendment 2025-03-14.
Trial Details
NCT Number NCT06270199
Lead Sponsor Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
Conditions Bronchopulmonary Dysplasia
Enrollment 75 participants
Start Date 2024-01-11
Primary Completion 2025-12 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2025-03-17